MTOR and small cell lung carcinoma: However, the mechanism of chemotherapy resistance in small cell lung cancer, which is characterized by many abnormalities in signaling pathways involving PIK3CA (PI3K/Protein kinase B [Akt]/the mammalian target of rapamycin [mTOR] pathway), may be informative.